Compare MRVI & RXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRVI | RXT |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2020 | 2020 |
| Metric | MRVI | RXT |
|---|---|---|
| Price | $7.29 | $3.91 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $4.13 | $1.71 |
| AVG Volume (30 Days) | 4.6M | ★ 6.1M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 14.29 | ★ 75.13 |
| EPS | ★ N/A | N/A |
| Revenue | $185,743,000.00 | ★ $2,685,700,000.00 |
| Revenue This Year | $12.54 | N/A |
| Revenue Next Year | $7.87 | $1.35 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.55 | $0.39 |
| 52 Week High | $9.42 | $8.60 |
| Indicator | MRVI | RXT |
|---|---|---|
| Relative Strength Index (RSI) | 47.43 | 48.92 |
| Support Level | $5.54 | $2.88 |
| Resistance Level | $7.44 | $3.56 |
| Average True Range (ATR) | 0.33 | 0.24 |
| MACD | -0.14 | 0.09 |
| Stochastic Oscillator | 17.23 | 79.75 |
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Rackspace Technology Inc is an end-to-end, hybrid, multi-cloud technology services company. It designs, builds, and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services, Data, Colocation, Cloud, Managed Hosting, Professional Services, and Security and Compliance. It has two reportable segments: Private Cloud and Public Cloud. Maximum revenue is generated from the Public Cloud segment, which offers cloud solutions through managed services, elastic engineering, and professional services offerings for customer environments hosted on the AWS, Microsoft Azure, and Google Cloud public cloud platforms. Geographically, the company derives its key revenue from the U.S.